RecallDepth
Class III Terminated

Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703, USA. Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad-382 210, India NDC 16729-472-08 (Vial NDC 16729-472-30)

Company
Accord Healthcare, Inc.
Recall Initiated
January 28, 2021
Posted
February 17, 2021
Recall Number
D-0250-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
502 cartons
Firm Location
Durham, NC, United States

Reason for Recall

Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled for 1 mL vials

Distribution

Nationwide

Lot / Code Info

Lot: M2013645 Exp. Aug. 2022

More recalls by Accord Healthcare, Inc.

View all recalls by this company →

Other recent Class III Drug recalls